New study examines immunotherapy outcomes in american indian cancer patients
NCT ID NCT05863052
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study reviews medical records of 72 American Indian patients treated with immunotherapy for cancers like lung cancer, melanoma, and kidney cancer. Researchers compare their outcomes—such as how long the cancer is controlled and side effects—to those of White patients. The goal is to identify any healthcare disparities and guide future research.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
immunotherapy
What this could lead to
If successful, this could reveal differences in how well immunotherapy works for American Indian patients and point to ways to improve their cancer care.
What could go wrong
This is a small, retrospective study that only looks at past data, so it cannot prove cause and effect. Results may not apply to all American Indian populations.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SOLID TUMOR are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Arizona Cancer Center at the Unvieristy of Arizona
Tucson, Arizona, 85719, United States
-
Avera Cancer Institute
Sioux Falls, South Dakota, 57105, United States
-
Huntsman Cancer Institute at the University of Utah
Salt Lake City, Utah, 84112, United States
-
Monument Health Cancer Care Institute
Rapid City, South Dakota, 57701, United States
-
Stephenson Cancer Center
Oklahoma City, Oklahoma, 73117, United States
-
University of New Mexico Comprehensive Cancer Center
Albuquerque, New Mexico, 87102, United States